Open AccessScalp Cooling in Daily Clinical Practice for Breast Cancer Patients Undergoing Curative Chemotherapy: A Multicenter Interventional Study
Author(s) -
E. Gianotti,
Giorgia Razzini,
Matteo Bini,
Caterina Crivellaro,
A. Righi,
Simona Darecchio,
Stefania Lui,
Maria Laura Basiricò,
Silvia Cocconi,
Katia Cagossi,
Annachiara Ferrari,
Fabrizio Artioli
Publication year - 2019
Publication title -
asia-pacific journal of oncology nursing
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.542
H-Index - 9
eISSN - 2349-6673
pISSN - 2347-5625
DOI - 10.4103/apjon.apjon_4_19
Subject(s) - hair loss , taxane , medicine , common terminology criteria for adverse events , tolerability , breast cancer , chemotherapy , anthracycline , scalp , adverse effect , cancer , surgery , oncology , dermatology
Chemotherapy-induced alopecia is a common and distressful side effect, especially among breast cancer patients. Scalp cooling (SC) can reduce hair loss during anthracycline- and taxane-based chemotherapy. This study assessed the effectiveness of SC in daily clinical practice in three Italian oncology units.